{"id":395811,"date":"2025-03-13T01:05:00","date_gmt":"2025-03-13T00:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=395811"},"modified":"2025-03-13T07:43:54","modified_gmt":"2025-03-13T06:43:54","slug":"produits-biologiques-et-jak-i-le-meilleur-de-deux-mondes","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/produits-biologiques-et-jak-i-le-meilleur-de-deux-mondes\/","title":{"rendered":"Produits biologiques et JAK-i &#8211; le meilleur de deux mondes"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>En Suisse, les anticorps monoclonaux actuellement autoris\u00e9s (dupilumab, tralokinumab, lebrikizumab) ainsi que les inhibiteurs de Janus kinase (JAK) (baricitinib, abro-citinib, upadacitinib) peuvent \u00eatre utilis\u00e9s comme traitement syst\u00e9mique de &#8220;premi\u00e8re ligne&#8221; chez les patients atteints de dermatite atopique, apr\u00e8s une r\u00e9ponse insuffisante au traitement topique. Le choix est donc vaste &#8211; la question des crit\u00e8res de d\u00e9cision subjectifs et objectifs est d&#8217;autant plus importante. <\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fproduits-biologiques-et-jak-i-le-meilleur-de-deux-mondes%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>En Suisse, les anticorps monoclonaux actuellement autoris\u00e9s (dupilumab, tralokinumab, lebrikizumab) ainsi que les inhibiteurs de Janus kinase (JAK) (baricitinib, abro-citinib, upadacitinib) peuvent \u00eatre utilis\u00e9s comme traitement syst\u00e9mique de &#8220;premi\u00e8re ligne&#8221;&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fproduits-biologiques-et-jak-i-le-meilleur-de-deux-mondes%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":395812,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Dermatite atopique","footnotes":""},"category":[11549],"tags":[67783,23493,17473,12636,13449,58236,65756,17477,81608,12608,13315,81609],"powerkit_post_featured":[],"class_list":["post-395811","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","tag-abrocitinib-fr","tag-anticorps-monoclonaux","tag-baricitinib-fr","tag-dermatite-atopique-fr","tag-dupilumab-fr","tag-firstline-fr","tag-inhibiteurs-de-janus-kinase","tag-inhibiteurs-jak","tag-lebriki-zumab-fr","tag-therapie-systemique","tag-tralokinumab-fr","tag-upad-acitinib-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-14 22:46:27","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":395808,"slug":"biologici-e-jak-i-il-meglio-dei-due-mondi","post_title":"Biologici e JAK-i - il meglio dei due mondi","href":"https:\/\/medizinonline.com\/it\/biologici-e-jak-i-il-meglio-dei-due-mondi\/"},"pt_PT":{"locale":"pt_PT","id":395805,"slug":"biologicos-e-jak-i-o-melhor-de-dois-mundos","post_title":"Biol\u00f3gicos e JAK-i - o melhor de dois mundos","href":"https:\/\/medizinonline.com\/pt-pt\/biologicos-e-jak-i-o-melhor-de-dois-mundos\/"},"es_ES":{"locale":"es_ES","id":395802,"slug":"biologicos-y-jak-i-lo-mejor-de-ambos-mundos","post_title":"Biol\u00f3gicos y JAK-i: lo mejor de ambos mundos","href":"https:\/\/medizinonline.com\/es\/biologicos-y-jak-i-lo-mejor-de-ambos-mundos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/395811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=395811"}],"version-history":[{"count":3,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/395811\/revisions"}],"predecessor-version":[{"id":397012,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/395811\/revisions\/397012"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/395812"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=395811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=395811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=395811"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=395811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}